<DOC>
	<DOCNO>NCT02162849</DOCNO>
	<brief_summary>The goal clinical research study learn varenicline nicotine patch help people different type emotion attention level quit smoking .</brief_summary>
	<brief_title>Reward Sensitivity Pharmacotherapy Smoking Cessation</brief_title>
	<detailed_description>Study Groups : If agree take part study , randomly assign ( roll dice ) 1 2 study group . This do one know one study group well , , bad group . You equal chance assign Group 1 2 . - If Group 1 , receive varenicline placebo patch . A placebo drug . It look like study drug design treat disease illness . It design compare study drug learn study drug real effect . - If Group 2 , receive active nicotine patch placebo tablet . Neither study doctor know group assign . However , need safety , study staff able find receiving . Study Drug Administration : You start take assign study drug ( ) day Visit 1 . You take varenicline/placebo tablet mouth cup ( 8 ounce ) water eat full meal . On Days 1-3 , take 1 dose study drug morning . Starting Day 4 , every day , take 1 dose morning 1 dose evening ( total 2 dos study drug day ) . You must return study drug bottle well unused study drug study staff study visit . You apply nicotine/placebo patch upper arm . You put slightly different place day avoid skin irritation . You may take patch night avoid sleep problem . You give study diary record many cigarette smoke ( ) day study . You must return study diary unused study drug , patch , and/or container study visit . Study Visits ( Visits 1-7 ) : At every study visit : - You complete questionnaire several topic , include depression , suicide , smoke behavior , effect study drug . These questionnaire take 30-45 minute total complete . - You give opportunity complete questionnaire verbally study staff member ( either phone person depend visit number ) electronically computer use website administer online survey development company call Qualtrics . - You receive counsel quit smoking , talk possible `` trigger '' smoke strategy deal quit smoking . These session take 15 minute . At Visits 1 , 4 6 : - Urine collect routine test check cotinine , nicotine , anabasine level . Cotinine chemical release body break nicotine show whether much recently smoke . Anabasine use show nicotine find blood due nicotine replacement therapy tobacco use . - Your CO level weight . measure . - If one screening , physical exam . - If complete one screen Visit 1 , complete EEG/lab session . - If become pregnant , urine collect pregnancy test . - At V1 , CO machine test result unclear , study staff think appropriate , NicAlert test performed . Urine collect NicAlert test , sensitive detecting level smoke CO machine . During counsel Day 8 , set `` quit date '' stop smoke 1 week start take study drug/placebo . You quit smoke quit date . You may also set goal reduce smoke . You try stay smoke-free quit date . You also give drug instruction sheet , card emergency contact information , participant manual help follow along topic discuss counsel . Visits 2 , 3 , 5 7 conduct phone . You complete questionnaire several topic ( either phone electronically ) , include depression , mood , smoke behavior , effect study drug . You also ask drug may take . Each call take 25-45 minute . The study staff call 1 day quit date 3 day quit date check progress quit smoking . Each call take 10-15 minute . Lab Session : You take part lab session Visit 1 test brain activity . You ask watch slide . The slide include picture people , nature , artwork . Slides show nude people , medical procedure , victim car crash also show . You show example slide begin procedure give opportunity withdraw study . During lab session , brain electrical activity check electroencephalogram ( EEG ) . To , small sensor place scalp face . You drink 2 cup coffee caffeinated drink least 2Â½ hour session . At lab session , may ask smoke cigarette doctor think need show normal smoking behavior . You also complete computer task , include questionnaire measure emotions attention level . These task take 90 minute complete . The lab session may last 2 hour . Ecological Momentary Assessments ( EMA ) : EMA use gather information mood craving happen day-to-day life . At randomization visit , loan smart phone device , ask complete questionnaire device different time everyday throughout active treatment phase ( 12 week ) . In questionnaire , ask event previous day , cigarette per day , alcohol intake , mood , sleep , motivation , whether take prescribe drug time . These questionnaire take 20 minute per day complete . Length Treatment : You receive study drug/placebo 12 week . You take study early doctor think best interest unable follow study direction . Your participation study follow-up visit . End-of-Treatment Visit ( Visit 8 ) : After finish take study drug/placebo , follow test procedure perform : - Your CO level measure . - Blood ( 2 teaspoon ) draw check liver kidney function . - Urine collect measure nicotine , anabasine , cotinine level . - You complete questionnaire complete regular study visit . - You receive counsel quit smoking . - If become pregnant , urine collect pregnancy test . Follow-Up Visits ( Visits 9 10 ) : At 3 6 month stop smoke , follow test procedure perform : - Your CO level measure . - Urine collect measure nicotine , anabasine , cotinine level . - You complete questionnaire complete regular study visit . This investigational study . Varenicline nicotine patch FDA approve commercially available help people stop smoking . The study doctor explain study drug design work . Up 160 participant enrol portion study . All take part MD Anderson .</detailed_description>
	<mesh_term>Nicotine</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<criteria>1 . Age : 1875 year old 2 . Smoking 5 cigarette little cigar per day , average , within 2 month precede screen visit expire carbon monoxide ( CO ) great equal 6 part per million ( ppm ) . ( &lt; /= 5 , NicAlert Strip &gt; 2 ) . 3 . Interested treatment might change smoke behavior 4 . Able follow verbal write instruction English complete aspect study 5 . Provide informed consent agree assessment study procedures 6 . Have address telephone number may reach 7 . Be participant household 1 . Within month immediately precede screen visit , use form tobacco product cigarettes little cigar 3 day within week individual refuse refrain tobacco use course study . 2 . Current enrollment plan enroll another smoking cessation program next 12 month 3 . Plan use nicotine substitute ( i.e. , OTC prescription medication smoke cessation ) smoke cessation treatment next 12 month 4 . Uncontrolled hypertension ( systolic blood pressure ; SBP great 180 diastolic blood pressure ; DBP great 110 ) 5 . History severe kidney disease ( e.g chronic acute kidney failure ) creatinine clearance 30 and/or severe liver disease liver test 4 time upper normal level 6 . Laboratory evaluation ( kidney liver ) outside normal limit potential clinical significance opinion investigator 7 . Serious unstable disease within past 3 month 8 . History ( last 3 month ) abnormal heart rhythm , cardiovascular disease ( stroke , angina , heart attack ) may result ineligibility . These condition evaluate case case basis Study Physician . 9 . Current use certain medication : ( 1 ) Smoking cessation med ( last 7 day ) , i.e. , Wellbutrin , Bupropion , Zyban , NRT , Chantix , ( 2 ) Certain medication treat depression ( last 14 day ) , i.e . MAOIs Elavil ( Amitriptyline ) , ( 3 ) A case case determination make study physician medication precautionary list , i.e . nitroglycerin , ( 4 ) Daily use opioids 30 day phone screen screen exclusionary however PRN use allow ( i.e. , 3:7 day per week le frequent , use less month 's duration . 10 . Meet criterion follow psychiatric and/or substance use disorder assess MINI International Neuropsychiatric Interview ( MINI ) : item C ( current manic hypomanic episode ) , I ( alcohol abuse Alcohol Addendumpast 6 month ; current alcohol dependence ) , J ( substance abuse Substance Abuse Addendum past 6 month ; current substance dependence ) , K ( current psychotic disorder current mood disorder psychotic feature ) . Individuals meet criterion nonexclusionary psychiatric disorder consider clinically unstable and/or unsuitable participate determine Principal Investigator and/or Study Physician . 11 . Individuals rat moderate ( 916 ) high ( 17 great ) suicidality assess Module B MINI . 12 . Psychiatric hospitalization within 1 year screening date . 13 . A positive urine pregnancy test screening period . Women two year postmenopausal , tubal ligation partial full hysterectomy subject urine pregnancy test . 14 . Pregnant , breastfeed childbearing potential protect medically acceptable , effective method birth control enrol study . Medically acceptable contraceptive include : ( 1 ) approve hormonal contraceptive ( birth control pill , patch , implant injection ) , ( 2 ) barrier method ( condom diaphragm ) use spermicide , ( 3 ) intrauterine device ( IUD ) . Contraceptive measure sell emergency use unprotected sex acceptable method routine use . 15 . History hypersensitivity allergic reaction Varenicline , NRT , component formulation . 16 . Any medical psychiatric condition , illness , disorder , concomitant medication could compromise participant safety treatment , determine Principal Investigator and/or Study Physician . 17 . Subject consider investigator unsuitable candidate receipt investigational drug , unstable follow throughout entire duration study . 18 . Positive toxicology screen follow drug : cocaine , opiates , methadone , benzodiazepine , barbiturate , amphetamine , methamphetamine , PCP , THC . A . Participants valid prescription opiate , benzodiazepine , barbiturate , amphetamine methadone exclude . B . Participants fail toxicology screen allow rescreen . If test positive , allowed return . 19 . Must visual auditory problem investigator opinion would interfere completion study assessment 20 . Unwilling change hairstyle remove wig necessary appointment accommodate net require worn scalp study procedure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Tobacco Use Cessation</keyword>
	<keyword>Smoking Cessation</keyword>
	<keyword>Cancer Prevention</keyword>
	<keyword>Behavioral Counseling</keyword>
	<keyword>Nicotine Replacement Therapy</keyword>
	<keyword>NRT</keyword>
	<keyword>Nicotine patch</keyword>
	<keyword>Placebo patch</keyword>
	<keyword>Placebo pill</keyword>
	<keyword>Sugar pill</keyword>
	<keyword>Varenicline</keyword>
	<keyword>Chantix</keyword>
	<keyword>Questionnaires</keyword>
	<keyword>Surveys</keyword>
	<keyword>Saliva test</keyword>
</DOC>